WhatistheSymbol
Watson Pharmaceuticals Inc trades in the stock market under the ticker symbol of WPI. Search for the ticker of any public company above using the 'Get Ticker' search in red.

Who is Watson Pharmaceuticals Inc?

Watson Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacturing, marketing, sale, and distribution of generic and brand pharmaceutical products focused on urology and women’s health in the United States, western Europe, Canada, Australasia, South America, and South Africa. The company offers its products for therapeutic categories, such as central nervous system, hormones and synthetic substitutes, cardiovascular, anti-infective agents, and urology. It operates in three segments: Global Generics, Global Brands, and Distribution. The Global Generics segment develops, manufactures, and sells generic pharmaceutical products, as well as distributes generic versions of third parties’ brand products. This segment offers various dosage forms, such as oral solids, transdermals, injectables, inhalation products, and transmucosals for indications, including pregnancy prevention, pain management, depression, hypertension, and smoking cessation. The Global Brands segment promotes and co-promotes Rapaflo, Gelnique, Trelstar, Crinone, ella, INFeD, AndroGel, and Femring branded products; and markets its products through sales professionals. It also sells various non-promoted products. The Distribution segment distributes generic and certain select brand pharmaceutical products manufactured by third parties, as well as by the company, primarily to independent pharmacies, pharmacy chains, pharmacy buying groups, and physicians’ offices. The company sells its generic and brand pharmaceutical products primarily to drug wholesalers, retailers, and distributors, including national retail drug and food store chains, hospitals, clinics, mail order, government agencies, and managed healthcare providers, such as health maintenance organizations and other institutions. Watson Pharmaceuticals, Inc. was founded in 1983 and is headquartered in Parsippany, New Jersey.

www.watson.com
6,686 Employees
Last Reported Date: 02/16/12
Founded in 1983
Last $86.89 USD
Change Today +0.99 / 1.15%
Volume 560.6K
As of 6:40 PM 10/25/12 All times are local (Market data is delayed by at least 15 minutes).

watson pharmaceuticals inc (WPI) Snapshot

Open
$86.74
Previous Close
$85.90
Day High
$87.69
Day Low
$86.36
52 Week High
10/16/12 - $89.90
52 Week Low
01/24/12 - $55.00
Market Cap
11.1B
Average Volume 10 Days
662.3K
EPS TTM
$3.23
Shares Outstanding
127.6M
WPI Does Not Pay Dividends
P/E TM
26.9x
WPI:US Historical Stock Quote
WPI:US Advanced Stock Chart

watson pharmaceuticals inc (WPI) Latest News

*Watson sells stake in Latin American drugmaker
More News

watson pharmaceuticals inc (WPI) Related News

No Related News Found

watson pharmaceuticals inc (WPI) Key Developments

Watson Pharmaceuticals, Inc. Receives Favorable Court Decision Regarding Generic Actos Approval

Watson Pharmaceuticals, Inc. confirmed that U.S. District Court for the District of Columbia has granted summary judgment in favor of Watson and ordered the U.S. Food and Drug Administration (FDA) to approve Watson's generic version of Actos(R) (Pioglitazone Hydrochloride 15 mg, 30 mg and 45 mg tablets). Watson plans to begin shipping the product immediately upon receipt of final FDA approval. On August 15, 2012, Watson announced that it had filed suit against the FDA challenging the Agency's decision regarding Watson's entitlement to shared exclusivity for its generic version of Actos(R) (Pioglitazone Hydrochloride 15 mg, 30 mg and 45 mg tablets).

Watson Pharmaceuticals, Inc. Announces Watson Laboratories, Inc-Florida Receives Approval from U.S. Food and Drug Administration on its Abbreviated New Drug Application for Trospium Chloride Extended-Release Capsules, the Generic Equivalent to Allergan's Sanctura XR

Watson Pharmaceuticals, Inc. announced that its subsidiary Watson Laboratories, Inc-Florida has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Trospium Chloride Extended-release Capsules, the generic equivalent to Allergan's Sanctura XR(R). Watson intends to begin shipping the product immediately. Sanctura XR(R) is indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and urinary frequency. For the 12 months ending July 31, 2012, Sanctura XR(R) had total U.S. sales of approximately $67 million according to IMS Health data.

Watson Pharmaceuticals, Inc. Announces Watson Laboratories, Inc. Receives Approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application

Watson Pharmaceuticals, Inc. announced that its subsidiary Watson Laboratories, Inc. has received approval from the U.S. Food and Drug Administration (FDA) on its abbreviated new drug application (ANDA) for Irbesartan Tablets USP, 75 mg, 150 mg and 300 mg, the generic equivalent to Sanofi's Avapro(R). Watson intends to begin shipping the product immediately. Avapro(R) is indicated for the treatment of hypertension when used alone or in combination with other antihypertensive agents. It is also indicated for the treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria (>300 mg/day) in patients with type 2 diabetes and hypertension. For the 12 months ending August 31, 2012, Avapro(R) and its generic equivalents had total U.S. sales of approximately $390 million according to IMS Health data.

Most Popular on

The Five Scariest Airports to Land a Plane
Why Women Earn Less Than Men a Year Out of School
The Surprises in the $1 Billion Bank Suit
Apple’s Slim iMac Far Outshines the New iPad Mini
Convincing Women in China They're Too Hairy
More News
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WPI:US $86.89 USD +0.99

WPI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Forest Laboratories Inc $34.62 USD +0.41
Life Technologies Corp $48.62 USD +0.78
Mylan Inc/PA $25.00 USD +1.06
Perrigo Co $117.37 USD +0.22
UCB SA €44.32 EUR +0.155
 

Industry Analysis

WPI

Industry Average

Valuation WPI Industry Range
Price/Earnings 69.7x
Price/Sales 2.0x
Price/Book 3.1x
Price/Cash Flow 17.8x
TEV/Sales 1.7x
 | 

Post a JobJobs

  • Corona, CA | Watson Pharmaceuticals
    Posted: Oct 24
  • Corona, CA | Watson Pharmaceuticals
    Posted: Oct 24
  • Fort Lauderdale, FL | Watson Pharmaceuticals
    Posted: Oct 23
  • Fort Lauderdale, FL | Watson Pharmaceuticals
    Posted: Oct 22
Simply Hired

Sponsored Links

No related news found for this Watson Pharmaceuticals Inc.
Subject Author Date
Upgrade Today citamar 2012-10-16 12:10:17
Lidoderm Settlement- Big News thoughful14 2012-10-16 12:10:13
Downgrade today jimbollini 2012-10-16 12:10:04
News-- Adderall thoughful14 2012-10-16 12:09:59
Deal Update thoughful14 2012-10-16 12:09:54
GS addes WPI to Conviction buy list $87 getintoh20 2012-10-16 12:09:50
where are the retail investors? spwangsu 2012-10-16 12:09:44
Significant article thoughful14 2012-10-16 12:09:40
After I read I bought teva p/e 8 babajon5babajon5 2012-10-16 12:09:34
Watson 2Q2012 Non-GAAP Diluted EPS Increases 41% to $1.42; Net Revenue Increases 25% bluecheese4u 2012-10-16 12:09:30
what the hell? zeppelinman2567 2012-10-16 12:09:22
So, When's the Split? buffumjr18 2012-10-16 12:09:15
All on board! oim1257 2012-10-16 12:09:11
New all time high close thoughful14 2012-10-16 12:09:07
Is the FDA picking winners and losers... congress502000 2012-10-16 12:09:00
Profit Taking citamar 2012-10-16 12:08:56
MAJOR NEWS thoughful14 2012-10-16 12:08:50
WPI ready for short pain patch infoanalysis 2012-10-16 12:08:45
Stock Split citamar 2012-10-16 12:08:33
Is Watson Pharmaceuticals, Inc about to plunge? I think I have figured it out emmabosserman 2012-10-16 12:08:26
wpi briarspratt 2012-10-16 12:08:18
Watson should buy TARO Pharmaceuticals? imho_dyodd 2012-10-16 12:08:14
Going for second jump oim1257 2012-10-16 12:08:09
Does Watson want to consider Impax IPXL under $30 before big Parkinson Approval? Remake o... cobbob46 2012-10-16 12:07:56
Also researched and see compliance and qaulity control execs left WPI and went to Impax. ... cobbob46 2012-10-16 12:07:51
  • 1
  • 0
  • 0

Get our Stock Market & Financial Investment news alerts in your inbox

Read our full disclaimer and privacy policy